Last reviewed · How we verify

Inhaled isopropyl alcohol — Competitive Intelligence Brief

Inhaled isopropyl alcohol (Inhaled isopropyl alcohol) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Aromatic inhalant antiemetic. Area: Gastroenterology / Acute Care.

marketed Aromatic inhalant antiemetic Gastroenterology / Acute Care Small molecule Live · refreshed every 30 min

Target snapshot

Inhaled isopropyl alcohol (Inhaled isopropyl alcohol) — Brooke Army Medical Center. Inhaled isopropyl alcohol vapor acts as a rapid-onset antiemetic by stimulating olfactory and trigeminal nerve pathways, reducing nausea signals to the brain.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Inhaled isopropyl alcohol TARGET Inhaled isopropyl alcohol Brooke Army Medical Center marketed Aromatic inhalant antiemetic

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Aromatic inhalant antiemetic class)

  1. Brooke Army Medical Center · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Inhaled isopropyl alcohol — Competitive Intelligence Brief. https://druglandscape.com/ci/inhaled-isopropyl-alcohol. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: